Fat burning
Fat actually burned
Also searched as Fat actually burned.
You want it roaring: brisk β-oxidation is how the body clears fat depots, a fatty liver included.
In depth
The mitochondrial pathway that dismantles fatty acids into cellular energy — the engine that empties stored and circulating fat.
What drives it
Fatty-acid oxidation increases it.
Kersten 1999, J Clin Invest 103:1489 — PPARα is the master regulator of the hepatic fatty-acid-oxidation response to fasting; PPARα-null mice fail to oxidize fat and accumulate hepatic lipid. PMID 10359558. Verified: PPAR-alpha activity governs ketogenesis and fatty-acid oxidation, and its de-repression during fasting is what licenses the oxidative program. this is the hepatic PPAR-alpha arm; the original primary (Hashimoto 2000, J Biol Chem 275:28918) is a mouse knockout demonstration that a defect in PPAR-alpha-inducible fatty-acid oxidation determines the phenotype -- a loss-of-function argument, not a gain-of-function one. The target list is explicit and spans the whole route: direct PPAR-alpha targets include the fatty-acid transport proteins CD36, SLC27A1 and FABP4, the mitochondrial entry transferase CPT1A, and the fatty-acyl-CoA dehydrogenases — uptake, entry and oxidation are induced together rather than sequentially. PPAR-alpha also induces lipophagy in the fasted state, in coordination with FXR which suppresses autophagy when fed. Knockout: the PPAR-alpha-null mouse is described as a model of fatty-acid oxidation disorders (Leone 1999). PPAR-alpha has the highest hepatic expression of the three PPARs and is activated by endogenous ligands — non-esterified and oxidized fatty acids, eicosanoids, bilirubin — so the fat itself switches on its own disposal. PMID 10359558
Lipid phosphatase increases it.
Finck 2006, Cell Metab 4:199 — lipin-1 is an inducible amplifier of the PGC-1α/PPARα pathway, potentiating fatty-acid-oxidation gene expression.
Carnitine shuttle increases it.
CPT1/β-oxidation study (PMC2724792) — carnitine palmitoyltransferase-1 catalyzes the rate-limiting step importing long-chain fatty acyl-CoAs into mitochondria for β-oxidation. PMC2724792. CPT1 is the rate-limiting entry step: fatty acyl-CoA cannot enter the mitochondrion to be oxidized except through the carnitine shuttle, so CPT1 activity sets the ceiling on beta-oxidation. entry is necessary but not sufficient — see the ACC-DKI knock-in on the AMPK → Fatty-Acid β-Oxidation link, where elevated malonyl-CoA did not reduce whole-body fatty-acid oxidation during exercise, showing CPT1-independent routes exist. PMC2724792
Alcohol metabolism reduces it.
Alcohol dehydrogenase consumes NAD+ to oxidize ethanol and raises the NADH/NAD+ ratio — and fatty-acid oxidation itself requires NAD+ to accept the hydrogen it releases. The raised ratio therefore inhibits fatty-acid oxidation directly, which is the step that precedes the fat. PMC11901390
Energy sensing increases it.
AMPK phosphorylates and inactivates ACC2, which lowers malonyl-CoA and so relieves its inhibition of CPT1 — the rate-limiting gate for fatty acids entering the mitochondrion. Fatty acids can then cross as carnitine esters and be oxidized (PMC2734509, PMC4552526). This is why AMPK activation raises fat oxidation within minutes, before any change in gene expression. Mechanism: AMPK inhibits ACC2, lowering malonyl-CoA, which relieves malonyl-CoA's inhibition of CPT1 and lets fatty acids enter mitochondria to be burned. It is de-repression, not activation. And a knock-in disproves that this route is required. Mice carrying alanine knock-ins at both AMPK phosphosites — ACC1 Ser79 and ACC2 Ser212 (acc-dki) — make acc activity and malonyl-CoA insensitive to AMPK. Those mice had normal exercise capacity and normal whole-body fatty-acid oxidation during treadmill running despite elevated muscle ACC2 activity and elevated malonyl-CoA. The authors conclude ACC2-independent pathways are capable of regulating fatty-acid oxidation during muscle contraction (PMC4552526). The textbook chain is real biochemistry but is not the only route, and not the necessary one under exercise. PMC2734509
Peroxisomes increases it.
Mitochondria cannot oxidize the longest fatty acids - peroxisomes shorten them first and hand them over. Carried by the intermediary-metabolism, micronutrient and redox reviews. doi 10.3390/nu18132141 · PMC9967593
Riboflavin cofactor increases it.
Acyl-CoA dehydrogenases are FAD-dependent. Carried by the intermediary-metabolism, micronutrient and redox reviews. doi 10.3390/nu18132141 · PMC9967593
Beta-3 receptor signaling increases it.
the beta3-AR plays a critical role in regulating lipolysis, glycolysis, and thermogenesis. ... reduction of beta3-AR lowered agonist-mediated increases in intracellular cAMP, lipolysis, and…. PMC8262278
The cell's go-signal increases it.
Forskolin... activates adenylate cyclase directly, raising cAMP independently of hormonal or receptor stimulation, and directly activates hormone-sensitive lipase via PKA phosphorylation, releasing free…. PMID 1435297
Releases stored fat increases it.
10.7554/eLife.31132 — 10.3390/biom10121699 — the reason a release lane only means something alongside a burning lane. Lipolysis produces 'the generation of FAs and glycerol, and their release from adipocytes' — fatty acids in the blood. What happens next is a separate question: they are oxidized, re-esterified, or delivered to other tissue. This is the limit of any 'fat release' claim. doi 10.7554/eLife.31132
Fat import gate increases it.
'The loss of the integral transmembrane transporter FATP1 in murine brown fat also marks attenuation in dissipating metabolic energy as heat' (doi 10.3389/fphys.2022.826314). A loss experiment: remove the gate and the burning falls. Release without import is only relocation. doi 10.3389/fphys.2022.826314
Fat uptake enzyme increases it.
'Aside from WAT lipolysis, other sources of FFAs can be derived through lipoprotein lipase (LPL)-mediated triglyceride-rich lipoprotein degradation. This pathway liberates FFAs into the vascular lumen' (doi 10.3389/fphys.2022.826314). A second, independent supply line to burning tissue. doi 10.3389/fphys.2022.826314
What it drives
It reduces Clears liver fat.
Hashimoto 2000, J Biol Chem 275:28918 — a defect in PPARα-inducible fatty-acid oxidation determines the severity of hepatic steatosis; robust β-oxidation clears hepatic fat.
It increases Recovery.
Fat oxidation is not merely fuel for repair, it is required for it: deleting Cpt2, the rate-limiting enzyme of mitochondrial fatty-acid oxidation, hampered muscle stem-cell expansion and differentiation after acute injury and markedly delayed regeneration — and acetate supplementation partially rescued the defect, tying the effect to acetyl-CoA availability and protein acetylation. PMC12048568
It increases Insulin sensitivity.
insulin, fasting insulin, type 2 diabetes and blood lipids share one literature: heart, kidney, liver, and metabolic diseases share interlinked pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial health issues. These four overlap by nature: fasting insulin is the level, insulin is the signaling, type 2 diabetes is the diagnosis and blood lipids are the substrate. The same driver legitimately reaches all four, and a reader should not mistake four arrows for four independent findings. doi 10.1038/s41581-026-01066-0 · PMC11725408
It reduces Fasting insulin.
insulin, fasting insulin, type 2 diabetes and blood lipids share one literature: heart, kidney, liver, and metabolic diseases share interlinked pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial health issues. These four overlap by nature: fasting insulin is the level, insulin is the signaling, type 2 diabetes is the diagnosis and blood lipids are the substrate. The same driver legitimately reaches all four, and a reader should not mistake four arrows for four independent findings. doi 10.1038/s41581-026-01066-0 · PMC11725408
It increases Lowers cholesterol.
insulin, fasting insulin, type 2 diabetes and blood lipids share one literature: heart, kidney, liver, and metabolic diseases share interlinked pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial health issues. These four overlap by nature: fasting insulin is the level, insulin is the signaling, type 2 diabetes is the diagnosis and blood lipids are the substrate. The same driver legitimately reaches all four, and a reader should not mistake four arrows for four independent findings. doi 10.1038/s41581-026-01066-0 · PMC11725408
It increases Liver.
10.1007/s00018-018-2860-6 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). Verbatim: “Cideb loss protected livers via increased β-oxidation, specifically through ATGL and PPARα activation”. doi 10.1007/s00018-018-2860-6 · PMID 40618957 · PMC12313214
It increases Gut barrier.
Verbatim: “One unifying theme is the induction of colonocyte hypoxia, driven by the aerobic oxidation of microbial-derived butyrate, as a critical factor promoting multiple cellular processes that support intestinal barrier function”. PMID 40405692
It increases Central fuel molecule.
Beta-oxidation yields acetyl-CoA. Carried by the intermediary-metabolism and clinical reviews. doi 10.1016/j.molmet.2023.101755 · PMC9967593
It increases Ketone fuel.
Ketone bodies are made from acetyl-CoA derived from fatty-acid oxidation. Carried by the intermediary-metabolism, micronutrient and clinical reviews. doi 10.3390/nu18132141 · PMC9967593
Blends that modulate it
Each blend page names this pathway and carries the study behind its claim.
See it on the map
Open the causal map to follow this pathway upstream and downstream, arrow by arrow, each with its study.